Molecular Partners Ag Stock Technical Analysis
| MLLCF Stock | USD 2.25 0.00 0.00% |
As of the 16th of February 2026, Molecular Partners secures the Standard Deviation of 4.82, mean deviation of 1.58, and Risk Adjusted Performance of (0.09). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Molecular Partners, as well as the relationship between them. Please verify Molecular Partners variance, maximum drawdown, as well as the relationship between the Maximum Drawdown and kurtosis to decide if Molecular Partners AG is priced some-what accurately, providing market reflects its recent price of 2.25 per share. Please also check out Molecular Partners jensen alpha, which is currently at (0.54) to check the company can sustain itself at a future point.
Molecular Partners Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Molecular, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to MolecularMolecular |
Molecular Partners 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Molecular Partners' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Molecular Partners.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in Molecular Partners on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Molecular Partners AG or generate 0.0% return on investment in Molecular Partners over 90 days. Molecular Partners is related to or competes with Innate Pharma, NDT Pharmaceuticals, Brii Biosciences, Scancell Holdings, JW (Cayman), NervGen Pharma, and Ascend Wellness. Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and... More
Molecular Partners Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Molecular Partners' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Molecular Partners AG upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 48.13 | |||
| Value At Risk | (3.61) |
Molecular Partners Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Molecular Partners' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Molecular Partners' standard deviation. In reality, there are many statistical measures that can use Molecular Partners historical prices to predict the future Molecular Partners' volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.54) | |||
| Total Risk Alpha | (0.94) | |||
| Treynor Ratio | 0.7956 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Molecular Partners' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Molecular Partners February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | 0.8056 | |||
| Mean Deviation | 1.58 | |||
| Coefficient Of Variation | (841.61) | |||
| Standard Deviation | 4.82 | |||
| Variance | 23.21 | |||
| Information Ratio | (0.13) | |||
| Jensen Alpha | (0.54) | |||
| Total Risk Alpha | (0.94) | |||
| Treynor Ratio | 0.7956 | |||
| Maximum Drawdown | 48.13 | |||
| Value At Risk | (3.61) | |||
| Skewness | (4.53) | |||
| Kurtosis | 33.77 |
Molecular Partners Backtested Returns
Molecular Partners has Sharpe Ratio of -0.12, which conveys that the firm had a -0.12 % return per unit of risk over the last 3 months. Molecular Partners exposes seventeen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Molecular Partners' Risk Adjusted Performance of (0.09), mean deviation of 1.58, and Standard Deviation of 4.82 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of -0.73, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Molecular Partners are expected to decrease at a much lower rate. During the bear market, Molecular Partners is likely to outperform the market. At this point, Molecular Partners has a negative expected return of -0.62%. Please make sure to verify Molecular Partners' maximum drawdown, as well as the relationship between the kurtosis and day typical price , to decide if Molecular Partners performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.15 |
Insignificant reverse predictability
Molecular Partners AG has insignificant reverse predictability. Overlapping area represents the amount of predictability between Molecular Partners time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Molecular Partners price movement. The serial correlation of -0.15 indicates that less than 15.0% of current Molecular Partners price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.15 | |
| Spearman Rank Test | 0.05 | |
| Residual Average | 0.0 | |
| Price Variance | 0.38 |
Molecular Partners technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Molecular Partners Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Molecular Partners volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Molecular Partners Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Molecular Partners AG on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Molecular Partners AG based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Molecular Partners price pattern first instead of the macroeconomic environment surrounding Molecular Partners. By analyzing Molecular Partners's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Molecular Partners's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Molecular Partners specific price patterns or momentum indicators. Please read more on our technical analysis page.
Molecular Partners February 16, 2026 Technical Indicators
Most technical analysis of Molecular help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Molecular from various momentum indicators to cycle indicators. When you analyze Molecular charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | 0.8056 | |||
| Mean Deviation | 1.58 | |||
| Coefficient Of Variation | (841.61) | |||
| Standard Deviation | 4.82 | |||
| Variance | 23.21 | |||
| Information Ratio | (0.13) | |||
| Jensen Alpha | (0.54) | |||
| Total Risk Alpha | (0.94) | |||
| Treynor Ratio | 0.7956 | |||
| Maximum Drawdown | 48.13 | |||
| Value At Risk | (3.61) | |||
| Skewness | (4.53) | |||
| Kurtosis | 33.77 |
Molecular Partners February 16, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Molecular stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | 0.00 | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 2.25 | ||
| Day Typical Price | 2.25 | ||
| Price Action Indicator | 0.00 |
Complementary Tools for Molecular Pink Sheet analysis
When running Molecular Partners' price analysis, check to measure Molecular Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Molecular Partners is operating at the current time. Most of Molecular Partners' value examination focuses on studying past and present price action to predict the probability of Molecular Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Molecular Partners' price. Additionally, you may evaluate how the addition of Molecular Partners to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |